NFKB1 and nonpapillary renal cell carcinoma: To confirm that Hippo pathway regulates NFκB signaling in ccRCC, we carried out RT-qPCR experiments to measure the change in NFκB target gene expression in ccRCC upon treatment with XMU-MP-1 at different doses or at a fixed concentration for increasing amount of time.